{"id":879,"date":"2021-10-07T03:15:53","date_gmt":"2021-10-07T03:15:53","guid":{"rendered":"https:\/\/longcovidalliance.org\/?p=879"},"modified":"2023-05-11T16:06:42","modified_gmt":"2023-05-11T16:06:42","slug":"pediatrics-covid-19-and-mis-c","status":"publish","type":"post","link":"https:\/\/longcovidalliance.org\/pediatrics-covid-19-and-mis-c\/","title":{"rendered":"Pediatrics, COVID-19, and MIS-C"},"content":{"rendered":"\n

From CircumSTANCE:<\/a>

October 6, 2021<\/strong><\/p>\n\n\n\n

\u201cMultisystem inflammatory syndrome in children (MIS-C) is a serious condition that appears to be linked to coronavirus disease 2019 (COVID-19). Most children who become infected with the COVID-19 virus have only a mild illness. But in children who go on to develop MIS-C, some organs and tissues \u2014 such as the heart, lungs, blood vessels, kidneys, digestive system, brain, skin or eyes \u2014 become severely inflamed. Signs and symptoms depend on which areas of the body are affected.<\/p>\n\n\n\n

MIS-C is considered a syndrome \u2014 a group of signs and symptoms, not a disease \u2014 because much is unknown about it, including its cause and risk factors. Identifying and studying more children who have MIS-C may help to eventually find a cause. The U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health are working with doctors and researchers across the country to learn more about risk factors for MIS-C, share data, and improve diagnosis and treatment of MIS-C.\u201d- MayoClinic.org<\/a><\/p>\n\n\n\n

<\/p>\n\n\n\n

\n
\n
\n
\n
\n
\n
\n